申请人:Bernotas Ronald Charles
公开号:US20090253711A1
公开(公告)日:2009-10-08
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物及其在治疗与或受5-HT6受体相关的疾病中的应用。